Abstract
Pharmacology is the science concerned with the interactions between chemical substances and living creatures. A chemical substance that interacts with animals is termed a “pharmacological agent”; it is also referred to colloquially as a “drug.” Psychopharmacology is the branch of neuropharmacology concerned more specifically with pharmaceutical agents that exert an effect on the central nervous system (CNS) and modify mental processes. Their specific purpose is the abolition or amelioration of psychopathological syndromes and mental disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literature
Selected Literature
Barbeau A, Sourkes TL, Murphy GF (1962) Les catecholamines dans la maladie de Parkinson. In: de Ajuriaguerra J (ed) Monoamines et système nerveux central. Masson & Cie, Paris, pp 247–262
Bertrand D, Galzi JL, Devillers-Thiery A, Bertrand S, Changeux JP (1993) Mutations at two distinct sites within the channel domain M2 alter calcium permeability of neuronal alpha 7 nicotine receptor. Proc Natl Acad Sci U S A 90:6971–6975
Birkmayer W, Hornykiewicz O (1961) Der l-Dioxyphenylalanineffekt bei der Parkinson-Akinese. Wien Klin Wochenschr 73:787–788
Björklund A, Dunnett SB (2007) Dopamine neuron system in the brain: an update. Trends Neurosci 30:194–202
Blackwell B, Marley E, Price J, Taylor D (1967) Hypertensive interactions between monoamine inhibitors and foodstuffs. Br J Psychiatry 113:349–365
Brickley SG, Mody I (2012) Extrasynaptic GABAA receptors: their function in the CNS and implications for disease. Neuron 73:23–34
Bromberg-Martin ES, Matsumoto M, Hikosaka O (2010) Dopamine in motivational control: rewarding, aversive and altering. Neuron 68:815–834
Cohen J (ed) (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Erlbaum, Hillsdale
Clark AJ (1937) Handbuch der experimentellen Pharmakologie. Vierter Band: General pharmacology. Springer, Berlin
Dean B (2002) Changes in the molecular structure of the brain in bipolar disorder: findings using human postmortem brain tissue. World J Biol Psychiatry 3:125–132
European Medicines Agency (2012) Guideline on good pharmacovigilance practices (GVP). Annex I – definitions. EMA/876333/2011 Rev.1
Gassmann M, Bettler B (2012) Regulation of neuronal GABAB receptor functions by subunit composition. Nat Rev Neurosci 13:380–394
Gerlach M, Gsell W, Kornhuber J, Jellinger K, Krieger V, Pantucek F, Vock R, Riederer P (1996) A post mortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia-thalamocortical circuits in Parkinson syndrome. Brain Res 741:142–152
Girault JA, Greengard P (2004) The neurobiology of dopamine signaling. Arch Neurol 61:641–644
Hassel B, Dingledine (2005) Glutamate. In: Siegel GJ, Albers RW, Brady S, Price DL (eds) Basic neurochemistry. Molecular, cellular and medical aspects, 7th edn. Academic Press, London, p 267–290
Jaber M, Robinson SW, Missale C, Caron MG (1996) Dopamine receptors and brain function. Neuropharmacology 35:1503–1519
Kandel ER, Schwartz JH, Jessel TM (eds) (1996) Neurowissenschaften: Eine Einführung. Spektrum Akademischer Verlag, Heidelberg/Berlin/Oxford
Kenakin T (2004) Principles: Receptor theory in pharmacology. Trends Pharmacol Sci 25:186–192
Kuhar MJ, Minneman K, Muly EC (2005) Catecholamines. In: Siegel GJ, Albers RW, Brady S, Price DL (eds) Basic neurochemistry. Molecular, cellular and medical aspects, 7th edn. Academic Press, London, p 211–225
Labarca C, Nowak MW, Zhang H, Tang L, Deshpande P, Lester HA (1995) Channel gating governed symmetrically by conserved leucine residues in the M2 domain of nicotinic receptors. Nature 376:514–516
Laupacis A, Sackett DL, Roberts RS (1988) An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 318:1728–1733
Muguruza C, Rodriguez F, Rozas I, Meana JJ, Uriguen L, Callado LF (2013) Antidepressant-like properties of three new alpha 2-adrenoceptor antagonists. Neuropharmacology 65:13–19
Murphy DL, Li W, Engel S, Wichems C, Andrews A, Lesch K-P, Uhl G (2001) Genetic perspectives on the serotonin transporter. Brain Res Bull 56:487–494
Mutschler E, Geisslinger G, Kroemer HK, Ruth P, Schäfer-Korting M (eds) (2008) Mutschler Arzneimittelwirkungen. Lehrbuch der Pharmakologie und Toxikologie, 9th edn. Wissenschaftliche Verlagsgesellschaft, Stuttgart
Nadler JV (2011) Aspartate release and signalling in the hippocampus. Neurochem Res 36:668–676
Nicholas AP, Hökfelt T, Pieribone PA (1996) The distribution and significance of CNS adrenoreceptors examined with in situ hybridization. Trends Pharmacol Sci 17:245–255
Olney JW (1978) Neurotoxicity of excitatory amino acids. In: McGeer EG, Olney JW (eds) Kainic acid as a tool in neurobiology. Raven, New York, pp 95–121
Paoletti P (2011) Review. Molecular basis of NMDA receptor functional diversity. Eur J Neurosci 33:1351–1365
Pupo A, Minneman K (2001) Adrenergic pharmacology: focus on the central nervous system. CNS Spectr 6:656–662
Riederer P, Youdim MBH (1986) Monoamine oxidase activity and monoamine metabolism in brains of Parkinsonian patients treated with l-deprenyl. J Neurochem 46:1359–1365
Snyder SH (2002) Forty years of neurotransmitters. A personal account. Arch Gen Psychiat 59:983–994
Taylor P, Brown JH (2005) Acetylcholine. In: Siegel GJ, Albers RW, Brady S, Price DL (eds) Basic neurochemistry. Molecular, cellular and medical aspects, 7th edn. Academic Press, London, p 185–209
Torres GE, Gainetdinov RR, Caron MG (2003) Plasma membrane monoamine transporters: structure and function. Nat Rev Neurosci 4:13–25
Wallman M-J, Gagnon D, Parent M (2011) Serotonin innervation of human basal ganglia. Eur J Neurosci 33:1519–1532
Watling KJ (2006) The Sigma-RBI handbook of receptor classification and signal transduction, 5th edn. Sigma-RBI, Natick
Waxham MN (2003) Neurotransmitter receptors. In: Squire LR, Bloom FE, McConnell SK, Roberts JL, Spitzer NC, Zigmond MJ (eds) Fundamental neuroscience, 2nd edn. Academic, London, pp 225–258
Zimmermann H (1993) Synaptic transmission. Cellular and molecular basis. Thieme, Oxford, p 75
Further Reading
Brady CT, Siegel GJ, Albers W, Price DL (eds) (2012) Basic neurochemistry. Principles of molecular, cellular and medical neurobiology, 8th edn. Elsevier, Amsterdam/Boston/Heidelberg/London/New York/Oxford/Paris/San Diego/San Francisco/Singapore/Sydney/Tokyo
Grahame-Smith DG, Aronson JK (eds) (2002) Oxford textbook of clinical pharmacology and drug therapy, 3rd edn. Oxford University Press, Oxford
Katzung BG, Masters SB, Trevor AJ (eds) (2012) Basic & clinical pharmacology, 12th edn. McGraw-Hill Companies, Columbus
Squire LR, Berg D, Bloom FE, du Lac S, Ghosh A, Spitzer NC (eds) (2013) Fundamental neuroscience, 4th edn. Elsevier, Amsterdam/Boston/Heidelberg/London/New York/Oxford/Paris/San Diego/San Francisco/Singapore/Sydney/Tokyo
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Wien
About this chapter
Cite this chapter
Gerlach, M. (2014). Fundamentals of Neuropsychopharmacology. In: Gerlach, M., Warnke, A., Greenhill, L. (eds) Psychiatric Drugs in Children and Adolescents. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1501-5_1
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1501-5_1
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1500-8
Online ISBN: 978-3-7091-1501-5
eBook Packages: MedicineMedicine (R0)